The protection of Rhein lysinate to liver in diabetic mice induced by high-fat diet and streptozotocin

Archives of Pharmacal Research

Volumn 38, Issue 5, 2015, Pages 885-892

  Lin, Ya Jun ^a   Hu, Gang ^a   Li, Kai Ji ^b   Zhao, Yu Fang ^b   Wei, Jie ^a   Zhen, Yong Zhan ^b  

^a BEIJING HOSPITAL   (China)

^b HEBEI UNITED UNIVERSITY   (China)

Author keywords

Diabetes; Hepatic protection; Inflammatory factors; Rhein lysinate

Indexed keywords

ANTHRAQUINONE DERIVATIVE; GLUCOSE BLOOD LEVEL; LYSINE; REACTIVE OXYGEN METABOLITE; RHEIN LYSINATE; STREPTOZOCIN;

ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; FATTY LIVER; GLUCOSE BLOOD LEVEL; LIPID DIET; LIVER; MALE; METABOLISM; MOUSE;

ANIMALS; ANTHRAQUINONES; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; FATTY LIVER; LIVER; LYSINE; MALE; MICE; MICE, INBRED C57BL; REACTIVE OXYGEN SPECIES; STREPTOZOCIN;

EID: 84939890784     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-014-0423-4     Document Type: Article

References (26)

1. Azzouz, I., H. Trabelsi, A. Hanini, S. Ferchichi, O. Tebourbi, M. Sakly, and H. Abdelmelek. 2014. Interaction between nanoparticles generated by zinc chloride treatment and oxidative responses in rat liver. International Journal of Nanomedicine 9: 223-229.
2. Chatterjee, S., A.L. Narasimhaiah, S. Kundu, and S. Anand. 2012. Anti-hyperglycaemic study of natural inhibitors for Insulin receptor. Bioinformation 8: 1195-1201.
3. Cheng, Y.S., X.D. Cong, D.Z. Dai, Y. Zhang, and Y. Dai. 2013. Argirein alleviates corpus cavernosum dysfunction by suppressing pro-inflammatory factors p66Shc and ER stress chaperone Bip in diabetic rats. Journal of Pharmacy and Pharmacology 65: 94-101.
4. Choi, S.B., B.S. Ko, S.K. Park, J.S. Jang, and S. Park. 2006. Insulin sensitizing and alpha-glucoamylase inhibitory action of sennosides, rheins and rhaponticin in Rhei Rhizoma. Life Sciences 78: 934-942.
5. Doycheva, I., N. Patel, M. Peterson, and R. Loomba. 2013. Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes. Journal of Diabetes and Its Complications 27: 293-300.
6. Du, H., J. Shao, P. Gu, B. Lu, X. Ye, and Z. Liu. 2012. Improvement of glucose tolerance by rhein with restored early-phase insulin secretion in db/db mice. Journal of Endocrinological Investigation 35: 607-612.
7. Gao, Q., W.S. Qin, Z.H. Jia, J.M. Zheng, C.H. Zeng, L.S. Li, and Z.H. Liu. 2010. Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy. Planta Medica 76: 27-33.
8. Giorda, C.B., A. Avogaro, M. Maggini, F. Lombardo, E. Mannucci, S. Turco, S.S. Alegiani, R. Raschetti, M. Velussi, and E. Ferrannini. 2008. Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors. Diabetes Care 31: 2154-2159.
9. Herman, W.H. 2007. Diabetes epidemiology: guiding clinical and public health practice: The Kelly West Award Lecture, 2006. Diabetes Care 30: 1912-1919.
10. Hu, G., J. Liu, Y.Z. Zhen, R. Xu, Y. Qiao, J. Wei, P. Tu, and Y.J. Lin. 2013. Rhein lysinate increases the median survival time of SAMP10 mice: Protective role in the kidney. Acta Pharmacologica Sinica 34: 515-521.
11. Hůlek, P., and I. Dresslerová. 2011. Steatosis and steatohepatitis in diabetic patient. Vnitrni Lekarstvi 57: 364-367.
12. Kohl, T., N. Gehrke, A. Schad, M. Nagel, M.A. Wörns, M.F. Sprinzl, T. Zimmermann, Y.W. He, P.R. Galle, M. Schuchmann, and J.M. Schattenberg. 2013. Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cells. Cell Death & Disease 4: e712.
13. Lin, Y., Y. Zhen, J. Liu, J. Wei, P. Tu, and G. Hu. 2013. Rhein lysinate inhibits monocyte adhesion to human umbilical vein endothelial cells by blocking p38 signaling pathway. Archives of Pharmacal Research 36: 1410-1418.
14. Lin, Y.J., and Y.S. Zhen. 2009. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice. Anti-cancer Drugs 20: 65-72.
15. Liu, J., Z. Chen, Y. Zhang, M. Zhang, X. Zhu, Y. Fan, S. Shi, K. Zen, and Z. Liu. 2013. Rhein protects pancreatic beta-cells from dynamin-related protein-1-mediated mitochondrial fission and cell apoptosis under hyperglycemia. Diabetes 62: 3927-3935.
16. Lucchesi, A.N., N.T. Freitas, L.L. Cassettari, S.F. Marques, and C.T. Spadella. 2013. Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats: a mechanism for diabetic chronic liver disease. Acta Cirurgica Brasileira 28: 502-508.
17. Martinello, F., S.M. Soares, J.J. Franco, A.C. Santos, A. Sugohara, S.B. Garcia, C. Curti, and S.A. Uyemura. 2006. Hypolipemic and antioxidant activities from Tamarindus indica L. pulp fruit extract in hypercholesterolemic hamsters. Food and Chemical Toxicology 44: 810-818.
18. Maurel, D.B., S. Pallu, C. Jaffré, N.L. Fazzalari, N. Boisseau, R. Uzbekov, C.L. Benhamou, and G.Y. Rochefort. 2012. Osteocyte apoptosis and lipid infiltration as mechanisms of alcohol-induced bone loss. Alcohol and Alcoholism 47: 413-422.
19. Olsnes, C., J. Olofsson, and H.J. Aarstad. 2011. MAPKs ERK and p38, but not JNK phosphorylation, modulate IL-6 and TNF-α secretion following OK-432 in vitro stimulation of purified human monocytes. Scandinavian Journal of Immunology 74: 114-125.
20. Pacana, T., and A.J. Sanyal. 2012. Vitamin E and nonalcoholic fatty liver disease. Current Opinion in Clinical Nutrition & Metabolic Care 15: 641-648.
21. Park, E.Y., H.J. Kim, Y.K. Kim, S.U. Park, J.E. Choi, J.Y. Cha, and H.S. Jun. 2012. Increase in insulin secretion induced by Panax ginseng berry extracts contributes to the amelioration of hyperglycemia in streptozotocin-induced diabetic mice. Journal of Ginseng Research 36: 153-160.
22. Park, M.Y., and S.T. Mun. 2013. Dietary carnosic acid suppresses hepatic steatosis formation via regulation of hepatic fatty acid metabolism in high-fat diet-fed mice. Nutrition Research and Practice 7: 294-301.
23. Sheng, X., X. Zhu, Y. Zhang, G. Cui, L. Peng, X. Lu, and Y.Q. Zang. 2012. Rhein protects against obesity and related metabolic disorders through liver X receptor-mediated uncoupling protein 1 upregulation in brown adipose tissue. International Journal of Biological Sciences 8: 1375-1384.
24. Wild, S., G. Roglic, A. Green, R. Sicree, and H. King. 2004. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053.
25. Zatalia, S.R., and H. Sanusi. 2013. The role of antioxidants in the pathophysiology, complications, and management of diabetes mellitus. Acta Medica Indonesiana 45: 141-147.
26. Zhang, Y., S. Fan, N. Hu, M. Gu, C. Chu, Y. Li, X. Lu, and C. Huang. 2012. Rhein reduces fat weight in db/db mouse and prevents diet-induced obesity in C57Bl/6 mouse through the inhibition of PPARγ signaling. PPAR Research 2012: 374936.